We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.68%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$413M
AUM Growth
-$3.2M
(-0.77%)
Cap. Flow
-$7.27M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
1,129
New
83
Increased
245
Reduced
309
Closed
247
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$21.4M |
| 2 |
Stellantis
STLA
|
+$18M |
| 3 |
CNH
CNH Industrial
CNH
|
+$11.6M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.3M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$6.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$23.5M |
| 2 |
Linde
LIN
|
+$8.45M |
| 3 |
Visa
V
|
+$5.42M |
| 4 |
Alcon
ALC
|
+$3.14M |
| 5 |
T-Mobile US
TMUS
|
+$3.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.6% |
| 2 | Technology | 15.31% |
| 3 | Miscellaneous | 15.03% |
| 4 | Industrials | 9.82% |
| 5 | Financials | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
NRG Energy
NRG
$22.6B
| $83.4K | 0.02% |
1,936
+66
| +4% | +$2.59K |
|
452
Dycom Industries
DY
$8.67B
| $80.5K | 0.02% |
859
-224
| -21% | -$18.9K |
|
453
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.45B
| $80.5K | 0.02% |
4,489
| – | – |
|
454
Kodiak Sciences
KOD
$2.06B
| $79.9K | 0.02% |
943
+932
| +8,473% | +$94.8K |
|
455
Genuine Parts
GPC
$18B
| $79.5K | 0.02% |
567
-38
| -6% | -$5.03K |
|
456
Rhythm Pharmaceuticals
RYTM
$6.75B
| $78.7K | 0.02% |
+7,886
| New | +$88.6K |
|
|
RCS
457
PIMCO Strategic Income Fund
RCS
$233M
| $78.5K | 0.02% |
11,566
-25,481
| -69% | -$183K |
|
458
Hydrofarm Holdings
HYFM
$4.43M
| $76.4K | 0.02% |
270
-78
| -22% | -$26.5K |
|
459
Amcor
AMCR
$19.4B
| $75.8K | 0.02% |
1,262
+87
| +7% | +$5.16K |
|
460
Gen Digital
GEN
$18.3B
| $74.7K | 0.02% |
2,874
+2,803
| +3,948% | +$70.9K |
|
461
Dow Inc
DOW
$21.7B
| $74.2K | 0.02% |
1,308
+123
| +10% | +$7.01K |
|
462
Marathon Petroleum
MPC
$116B
| $73.6K | 0.02% |
1,150
+1,081
| +1,567% | +$69.5K |
|
463
Snap-on
SNA
$19.3B
| $73.4K | 0.02% |
341
+16
| +5% | +$3.42K |
|
464
Omnicom Group
OMC
$21.8B
| $73.4K | 0.02% |
1,002
+985
| +5,794% | +$70.1K |
|
465
Cardinal Health
CAH
$54.1B
| $72.6K | 0.02% |
1,410
+1,381
| +4,762% | +$67.7K |
|
466
Emergent Biosolutions
EBS
$346M
| $72.6K | 0.02% |
1,670
-354
| -17% | -$16K |
|
467
Pultegroup
PHM
$22.4B
| $72.4K | 0.02% |
1,266
-42
| -3% | -$2.15K |
|
468
Edwards Lifesciences
EW
$51.5B
| $71.6K | 0.02% |
553
-686
| -55% | -$80K |
|
469
NovoCure
NVCR
$1.89B
| $71.3K | 0.02% |
950
-284
| -23% | -$28.5K |
|
470
Lumen
LUMN
$6.88B
| $70.9K | 0.02% |
5,646
+5,170
| +1,086% | +$65.8K |
|
471
Fox Class B
FOX
$24.9B
| $70.3K | 0.02% |
2,052
+2,029
| +8,822% | +$74.3K |
|
472
Northrop Grumman
NOC
$75.4B
| $69.7K | 0.02% |
180
-1,147
| -86% | -$427K |
|
473
Innovator US Equity Buffer ETF December
BDEC
$213M
| $69.1K | 0.02% |
1,962
-2,189
| -53% | -$74.9K |
|
474
Columbus McKinnon
CMCO
$465M
| $67.8K | 0.02% |
1,465
+184
| +14% | +$8.88K |
|
475
PG&E
PCG
$29.4B
| $63.9K | 0.02% |
5,266
+611
| +13% | +$7.16K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2021 Portfolio in Review
As of Q4 2021, Exane Derivatives held 1,129 positions worth $413M, down 0.77% from $417M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Exane Derivatives's Q4 2021 filing shows 83 new, 245 increased, 309 reduced and 247 closed positions. Its largest new stake was EngageSmart, Inc.: 45,605 shares worth $1.1M. The largest sale was UBS Group, an estimated $23.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 11% a quarter earlier, followed by Technology and Miscellaneous.
- Exane Derivatives's largest Q4 2021 buy was EngageSmart, Inc.: 45,605 shares worth $1.1M.
- Exane Derivatives added most to Ferrari in Q4 2021, an estimated $21.4M increase.
- Exane Derivatives's biggest Q4 2021 reduction was UBS Group, cutting an estimated $23.5M.
- Exane Derivatives fully exited Visa in Q4 2021, selling an estimated $5.42M.
- Exane Derivatives's ten largest holdings make up 30% of its $413M portfolio in Q4 2021.
- Exane Derivatives opened 83 new positions and closed 247 in Q4 2021.
- Exane Derivatives's portfolio value fell 0.77% quarter-over-quarter to $413M.
Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.